Patent · US Active

Method for treating arthritis

US8410174B2 · kind B2 · utility

1Cited by
26References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 21, 2012
Grant dateApr 2, 2013
Priority date
Expiry dateMar 21, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D317/58
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected from hydrogen, halogen, alkyl having 1 to 5 carbon atoms, electron donor groups such as alkoxy having 1-5 carbon atoms or hydroxy, electron acceptor groups selected from cyano, nitro, trifluoroalkyl or amide; alkylamino, benzoyloxy, nitroxy, phenyl or sulpho; and the pharmacologically active salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.